Patients and carers
Our mission is to make a positive difference to the lives of the individuals, carers and families who are affected by neurodegenerative diseases
We are drawing on decades of scientific, clinical and healthcare experience to understand the progression of Alzheimer’s disease, frontotemporal dementia and other neurodegenerative diseases to develop effective treatments.
Alzheimer’s today
As the world’s population ages, the prevalence of the disease is predicted to reach epidemic proportions.
Mild cognitive impairment
MCI is not a normal part of ageing, and understanding the difference is critical to getting an early diagnosis, and the right kind of support.
Alzheimer’s disease
Nearly 1 million people in the UK currently live with dementia, with Alzheimer’s disease the most common form. Our work could change this prognosis, potentially improving the lives of millions.
Frontotemporal dementia
This less common type of dementia can lead to personality changes and difficulties with speech and movement, often developing at a younger age than other types.